Not all patients with CLL have to have therapy. Despite all new advances, the iwCLL nevertheless recommends watchful observation for sufferers with asymptomatic ailment.86 This recommendation is based on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally trials concluded https://louisg332umb0.laowaiblog.com/profile